Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Grady Alsabrook

Vascular Surgery San Antonio, TX Medical Doctor

NPI 1699898643 CMS profile 76309

610 N Main Avenue, San Antonio, TX 78205

Open in the dashboard

General payments

$9,012

93 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Grady Alsabrook of San Antonio, TX is reported in the CMS Open Payments database as having received $9,012 across 93 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 65th percentile of Vascular Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $1,119 13
2024 General $197 5
2023 General $1,182 26
2022 General $1,021 19
2021 General $473 10
2020 General $4,628 9
2019 General $392 11

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Grady Alsabrook
  • Vascular Surgery median
  • Middle half of Vascular Surgery
  • National median

In program year 2025, general payments to Grady Alsabrook were reported at $1,119. Among 3,991 Vascular Surgery profiles paid that year, the median was $924 and the middle half received between $273 and $2,636.

Show as a table
Year Grady Alsabrook Vascular Surgery median Middle half National median
2019 $392 $796 $226–$2,363 $163
2020 $4,628 $348 $118–$1,110 $114
2021 $473 $471 $158–$1,421 $132
2022 $1,021 $725 $222–$2,183 $149
2023 $1,182 $836 $257–$2,440 $160
2024 $197 $909 $252–$2,619 $164
2025 $1,119 $924 $273–$2,636 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Silk Road Medical, Inc. $5,356 19 payments
  2. Philips Electronics North America Corporation $702 7 payments
  3. CVRx, Inc. $512 7 payments
  4. Shockwave Medical, Inc $408 3 payments
  5. Endologix, Inc. $360 4 payments
  6. LeMaitre Vascular, Inc. $332 10 payments
  7. W. L. Gore & Associates, Inc. $280 7 payments
  8. Cardiva Medical, Inc. $192 7 payments
  9. Shape Memory Medical Inc. $170 2 payments
  10. Medtronic Vascular, Inc. $125 4 payments
  11. Other $575 23 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $4,577 4 payments
  2. Food and Beverage $4,190 88 payments
  3. Travel and Lodging $245 1 payment
Products named General payments · program years 2019–2025
  1. ENROUTE Transcarotid Neuroprotection System Carotid Artery Disease $4,663 10 payments
  2. ENROUTE Transcarotid Stent System $4,663 10 payments
  3. ENHANCE Transcarotid Peripheral Access Kit Carotid Artery Disease $4,663 10 payments
  4. ENROUTE 0.014 Guidewire $4,663 10 payments
  5. ENROUTE Transcarotid Neuroprotection System Cardiology/Vascular Diseases $693 9 payments
  6. ENROUTE Transcarotid Stent $693 9 payments
  7. IGT Devices Undivided $600 1 payment
  8. Barostim Neo System $512 7 payments
  9. Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter $408 3 payments
  10. ENHANCE Transcarotid Peripheral Access Kit Cardiology/Vascular Diseases $280 5 payments
  11. Other $2,794 79 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 4 drugs

Part D claims

336

Median for Vascular Surgery: 122

Drug cost

$9,717

Median for Vascular Surgery: $14,135

Branded share of claims

71.1%

Median for Vascular Surgery: 71%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Xarelto Rivaroxaban Brand 12 $6,798
Clopidogrel Clopidogrel Bisulfate Brand 227 $1,742
Cilostazol Generic 71 $1,110
Tramadol Hcl Generic 26 $67

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 3,087 Part D prescribers listed as Vascular Surgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 113 billing codes

Paid by Medicare

$251,346

Of which drugs: $350

Medicare patients

362

Average age 75

Services billed

4,847

168 women, 194 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Ischemic heart disease 56%
Chronic kidney disease 53%
Diabetes 50%
Arthritis 49%
Heart failure 31%
Atrial fibrillation 31%
COPD 29%
Drugs given in the clinic that this provider billed Medicare Part B for
Drug given in the clinic Where Patients Services Paid by Medicare
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml Q9967 Office 30 3,483 $350

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

93 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Vascular Surgery in Texas

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record